Abstract
Objective
To elucidate the effects of antiepileptic drugs (AEDs) on bone health status of ambulatory epileptic children.
Methods
A total of 120 epileptic children aged 2–15 y were enrolled in three groups. The first group was on therapy with carbamazepine, phenobarbital or primidone. The second was treated with valproic acid and the third group was untreated. Serum calcium, phosphorous, total alkaline phosphatase, and parathyroid hormone levels were compared between groups. Bone mineral density tests were also performed at four sites of the lumbar spine and three sites of femoral neck and results were compared between the groups.
Results
Of all enrolled subjects, 67 patients (55.8 %) were vitamin D deficient. The three groups were not significantly different in terms of vitamin D, calcium, phosphorus, total alkaline phosphatase, and parathyroid hormone levels. While patients in first group had lower Z-score of femoral neck and lumbar spine compared to those on valproic acid, these values were also significantly different than that of the third group.
Conclusions
It can be concluded that both enzyme-inducing AEDs and non enzyme-inducing AEDs decrease bone mineral density (BMD). Also alkaline phosphatase (ALP) is affected in ambulatory epileptic children on enzyme-inducing AEDs. Nevertheless, valproic acid (a non-enzyme-inducing agent) does not have the mentioned side effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sillanpaa M. Epilepsy in children: prevalence, disability, and handicap. Epilepsia. 1992;33:444–9.
Fitzpatrick LA. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav. 2004;5:S3–15.
Verrotti A, Coppola G, Parisi P, Mohn A, Chiarelli F. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2010;112:1–10.
Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology. 2001;57:445–9.
Dent CE, Richens A, Rowe DFJ, Stamp TC. Osteomalacia with long term anticonvulsant therapy in epilepsy. Br Med J. 1970;4:69–72.
Pack AM, Olarte LS, Morrell MJ, Flaster E, Resor SR, Shane E. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav. 2003;4:169–74.
Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj FG. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology. 2002;58:1348–53.
Krishnamoorthy G, Karande S, Ahire N, Mathew L, Kulkarni M. Bone metabolism alteration on antiepileptic drug therapy. Indian J Pediatr. 2009;76:377–83.
Shellhaas R, Joshi S. Vitamin D and bone health among children with epilepsy. Pediatr Neurol. 2010;42:385–93.
Boluk A, Guzelipek M, Savli H, Temel I, Ozisik H, Kaygusuz A. The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res. 2004;50:93–7.
Beniczky SA, Viken J, Jensen LT, Andersen NB. Bone mineral density in adult patients treated with various antiepileptic drugs. Seizure. 2012;21:471–2.
Akın R, Okutan V, Sarıcı U, Altunbas¸ A, Gökçay E. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol. 1998;19:129–31.
Riggs BL, Melton III LJ, O’Fallon WM. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine anti fracture efficacy. Bone. 1996;18:197S–201.
Ecevit C, Aydogan A, Kavakli T, Altinoz S. Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol. 2004;31:279–82.
Babayigit A, Dirik E, Bober E, Cakmakci H. Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol. 2006;35:177–81.
Kumandas S, Koklu E, Gumus H, Koklu S, Kurtoglu S, Karakukcu M, et al. Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3. J Pediatr Endocrinol Metab. 2006;19:529–34.
Coppola G, Fortunato D, Mainolfi C, Porcaro F, Roccaro D, Signoriello G, et al. Bone mineral density in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy. Epilepsia. 2012;53:2172–7.
Pack AM, Morrell MJ, Marcus R, Holloway L, Flaster E, Done S, et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol. 2005;57:252–7.
El-Hajj Fuleihan G, Dib L, Yamout B, Sawaya R, Mikati M. Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone. 2008;43:149–55.
Baim S, Leonard MB, Bianchi ML. Official positions of the international society for clinical densitometry and executive summary of the ISCD pediatric position development conference. J Clin Densitom. 2008;11:6–21.
Bachrach LK. Osteoporosis and measurement of bone mass in children and adolescents. Endocrinol Metab Clin North Am. 2005;34:521–35.
Goulding A, Jones IE, Taylor RW. Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. J Pediatr. 2001;139:509–15.
van der Sluis IM, de Ridder MA, Boot AM. Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults. Arch Dis Child. 2002;87:341–7.
Conflict of Interest
None.
Source of Funding
Shahid Beheshti University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yaghini, O., Tonekaboni, S.H., Amir Shahkarami, S.M. et al. Bone Mineral Density in Ambulatory Children with Epilepsy. Indian J Pediatr 82, 225–229 (2015). https://doi.org/10.1007/s12098-014-1518-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-014-1518-0